ADDITIVITY OF NEBIVOLOL/VALSARTAN SINGLE-PILL COMBINATIONS VERSUS OTHER APPROVED SINGLE-PILL COMBINATIONS FOR HYPERTENSION

Background: The single-pill combination (SPC) comprising nebivolol (5 mg), a vasodilatory β1-selective antagonist/ β3 agonist, and valsartan (80 mg), an angiotensin receptor blocker, is the only FDA-approved β-blocker/renin-angiotensin-aldosterone system (RAAS) inhibitor SPC for hypertension....

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-03, Vol.69 (11), p.1692-1692
Main Authors: Ishak, Jack, Rael, Michael, Punzi, Henry, Gradman, Alan, Anderson, Lynn M, Patel, Mehul D, Ali, Sanjida, Ferguson, William, Neutel, Joel
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
FDA approval
Hypertension
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: The single-pill combination (SPC) comprising nebivolol (5 mg), a vasodilatory β1-selective antagonist/ β3 agonist, and valsartan (80 mg), an angiotensin receptor blocker, is the only FDA-approved β-blocker/renin-angiotensin-aldosterone system (RAAS) inhibitor SPC for hypertension.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(17)35081-7